Mohamad Saimi, N.I.; Salim, N.; Ahmad, N.; Abdulmalek, E.; Abdul Rahman, M.B.
Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation. Pharmaceutics 2021, 13, 59.
https://doi.org/10.3390/pharmaceutics13010059
AMA Style
Mohamad Saimi NI, Salim N, Ahmad N, Abdulmalek E, Abdul Rahman MB.
Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation. Pharmaceutics. 2021; 13(1):59.
https://doi.org/10.3390/pharmaceutics13010059
Chicago/Turabian Style
Mohamad Saimi, Norfatin Izzatie, Norazlinaliza Salim, Noraini Ahmad, Emilia Abdulmalek, and Mohd Basyaruddin Abdul Rahman.
2021. "Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation" Pharmaceutics 13, no. 1: 59.
https://doi.org/10.3390/pharmaceutics13010059
APA Style
Mohamad Saimi, N. I., Salim, N., Ahmad, N., Abdulmalek, E., & Abdul Rahman, M. B.
(2021). Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation. Pharmaceutics, 13(1), 59.
https://doi.org/10.3390/pharmaceutics13010059